Target intelligence / Profile preview

Piperine

Molecular classification
Alkaloid, Amide, Small molecule
01

Overview

Piperine is the primary pungent alkaloid found in black pepper (Piper nigrum) and long pepper (Piper longum) (Wikipedia, 2024). Although it is a bioactive small molecule rather than a biological target, it is of significant pharmacological interest due to its interactions with several key proteins in the human body (NIH, 2018). Its most notable role is as a bioavailability enhancer, achieved through the potent inhibition of metabolic enzymes like Cytochrome P450 3A4 (CYP3A4) and efflux transporters such as P-glycoprotein (ABCB1), which increases the systemic exposure of various drugs and nutrients (ResearchGate, 2026; NIH, 2023). Piperine also acts as an agonist for the Transient Receptor Potential Vanilloid 1 (TRPV1) ion channel, contributing to its effects on thermogenesis and pain sensation (NIH, 2005; BOC Sciences, 2024). Additionally, it exhibits anti-inflammatory, antioxidant, and anti-tumor properties by modulating signaling pathways such as NF-κB and STAT3 (NIH, 2018; ResearchGate, 2019). While frequently used as a dietary supplement adjuvant, its ability to alter the pharmacokinetics of other medications necessitates careful consideration of potential drug-drug interactions (NCATS, 2024). It has also been shown to modulate GABAA receptors, suggesting potential neuroprotective and sedative effects (NIH, 2011). Research continues to explore its potential in treating metabolic disorders like obesity and chronic inflammatory conditions (NIH, 2023).

Other names
1-PiperoylpiperidineBioperine(2E,4E)-5-(1,3-Benzodioxol-5-yl)-1-(piperidin-1-yl)penta-2,4-dien-1-one
02

Mechanism of action

Piperine acts as an agonist of the Transient Receptor Potential Vanilloid 1 (TRPV1) ion channel and a modulator of GABAA receptors (NIH, 2011; BOC Sciences, 2024). It also functions as a potent inhibitor of the metabolic enzyme Cytochrome P450 3A4 (CYP3A4) and the efflux transporter P-glycoprotein (ABCB1), which accounts for its role as a bioavailability enhancer (ResearchGate, 2026; MedChemExpress, 2024).

03

Biological functions

Bioavailability enhancementThermogenesisAnti-inflammatoryAntioxidantNeuroprotection
04

Disease associations

ObesityInflammationPainCancerNeurodegenerative disease
05

Safety considerations

Drug-drug interactions due to inhibition of CYP3A4 and P-glycoprotein (NIH, 2023)Gastrointestinal irritation at high doses (Wikipedia, 2024)Potential for increased toxicity of co-administered medications (NCATS, 2024)
06

Interacting drugs

Curcumin (ResearchGate, 2026)

5 more in the full profile.

Beyond the preview

Go deeper on Piperine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Piperine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call